[ORGANIZATION]
argenx
Featured in 13 tracked stories · first seen
Situations
Myasthenia gravis research and treatment in Italy
2 clusters · 13 sources · last updated
Latest: Italy advances research and treatments for Myasthenia Gravis
Efforts to manage and understand Myasthenia gravis, a rare autoimmune disease causing muscle weakness, have progressed through various clinical initiatives in Italy. Initial efforts included the ‘Training Xperience’ pro
Also covered in
-
Argenx to acquire Unnatural Products for up to $1.15 billion
[BUSINESS] · 4 sources ·
-
Halozyme and Argenx expand ENHANZE technology collaboration
[BUSINESS] · 2 sources ·
-
Argenx Medical Director emphasizes patient impact in neuropathy treatment
[HEALTH] · 3 sources ·
-
Argenx stock projected to rise 23% on biotech momentum
[BUSINESS] · 2 sources ·
-
Italy initiates regional meetings to manage immunoglobulin supply
[HEALTH] · 2 sources ·
-
Argenx shares surge following successful Phase III myositis study
[BUSINESS] · 4 sources ·